Health Care & Life Sciences » Medical Equipment & Supplies | Retractable Technologies Inc.

Retractable Technologies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
30,785.10
34,520.60
29,552.20
29,826.60
34,493.80
33,274.70
Cost of Goods Sold (COGS) incl. D&A
20,475.20
22,498.90
18,987.00
19,484.60
24,522.30
23,052.90
Gross Income
10,310.00
12,021.70
10,565.20
10,342.10
9,971.60
10,221.80
SG&A Expense
16,241.20
14,179.30
13,773.00
13,392.90
13,750.20
11,802.50
EBIT
5,931.20
2,157.60
-
3,050.90
3,778.60
1,580.70
Unusual Expense
-
-
7,724.80
456.10
-
260.50
Interest Expense
230.60
222.80
219.70
213.30
210.80
177.20
Pretax Income
6,122.90
2,346.40
4,322.20
3,693.80
3,923.60
1,353.30
Income Tax
91.00
8.20
7.90
1.10
187.60
13.30
Consolidated Net Income
6,213.90
2,354.60
6,620.00
3,694.90
3,736.00
1,339.90
Net Income
6,213.90
2,354.60
6,620.00
3,694.90
3,736.00
1,339.90
Net Income After Extraordinaries
6,213.90
2,354.60
6,620.00
3,694.90
3,736.00
1,339.90
Net Income Available to Common
7,129.90
3,269.80
5,910.60
4,399.90
4,441.00
2,044.90
EPS (Basic)
0.26
0.12
0.20
0.15
0.14
0.06
Basic Shares Outstanding
26,999.70
27,375.50
27,822.60
29,354.40
31,958.10
32,666.50
EPS (Diluted)
0.26
0.12
0.20
0.15
0.14
0.06
Diluted Shares Outstanding
26,999.70
27,375.50
29,481.30
29,354.40
31,958.10
32,666.50
EBITDA
4,647.00
1,083.00
2,349.50
2,178.00
2,943.60
693.90
Non-Operating Interest Income
38.90
33.90
24.90
26.50
65.70
144.10
Other After Tax Income (Expense)
-
-
2,305.70
-
-
-
Preferred Dividends
916.10
915.20
709.40
705.00
705.00
705

About Retractable Technologies

View Profile
Address
511 Lobo Lane
Little Elm Texas 75068
United States
Employees -
Website http://www.retractable.com
Updated 07/08/2019
Retractable Technologies, Inc. designs, develops, manufactures and markets safety needle devices for the healthcare industry. The company's VanishPoint products utilize a patented friction ring mechanism. The friction ring mechanism permits the automated retraction of the needle into the barrel of the syringe, directly from the patient, after delivery of the medication is completed.